Naveen Pemmaraju shared on LinkedIn:
“Proud to have Co-Chaired the inaugural MPN WorkshopNC24 with my great friend and amazing colleague Dr Ruben Mesa !!! What an amazing meeting with so many new ideas and new collaborations!
Wonderful engagement from our MPN field! Special thanks to our 2 excellent keynote speakers Dr Ross Levine speaking on JAK2 and Dr Jyoti Nangalia speaking on CALR. A huge thanks to Video Journal of Hematology and Hematological Oncology (VJHemOnc) and MPN Advocacy and MPN-RF and so many others for their support and participation!”
Source: Naveen Pemmaraju/LinkedIn
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
